Search Results - Antypiuk, Ada

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    S286: TARGETING CONDITIONING‐ELICITED NON‐TRANSFERRIN‐BOUND IRON BY TMPRSS6 SILENCING IMPROVES BONE MARROW TRANSPLANT OUTCOME

    S286: TARGETING CONDITIONING‐ELICITED NON‐TRANSFERRIN‐BOUND IRON BY TMPRSS6 SILENCING IMPROVES BONE MARROW TRANSPLANT OUTCOME by Antypiuk, Ada, Martinez, Alberto, Schaeper, Ute, Platzbecker, Uwe, Vinchi, Francesca

    Published in HemaSphere
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    S288: DIFFERENTIAL RECOVERY OF MACROPHAGE IRON DEFICIENCY BY ORAL IRON FORMULATIONS DETERMINES CELL INFLAMMATORY ACTIVATION IN ANEMIC CONDITIONS

    S288: DIFFERENTIAL RECOVERY OF MACROPHAGE IRON DEFICIENCY BY ORAL IRON FORMULATIONS DETERMINES CELL INFLAMMATORY ACTIVATION IN ANEMIC CONDITIONS by Antypiuk, Ada, Sharma, Richa, Brilli, Elisa, Tarantino, Germano, Vinchi, Francesca

    Published in HemaSphere
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages

    Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages by Patino, Edwin, Bhatia, Divya, Vance, Steven Z, Antypiuk, Ada, Uni, Rie, Campbell, Chantalle, Castillo, Carlo G, Jaouni, Shahd, Vinchi, Francesca, Choi, Mary E, Akchurin, Oleh

    Published in JCI insight
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Combination Therapy with Luspatercept and the Ferroportin Inhibitor Vamifeport Is Superior to Either Drug Alone in Improving Anemia and Reducing Myeloid Skewing in MDS

    Combination Therapy with Luspatercept and the Ferroportin Inhibitor Vamifeport Is Superior to Either Drug Alone in Improving Anemia and Reducing Myeloid Skewing in MDS by Antypiuk, Ada, Vance, Steven, Dürrenberger, Franz, Manolova, Vania, Vinchi, Francesca

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Myelodysplastic Syndromes Benefit from Iron-Restricted Bone Marrow Transplant in Preclinical Mouse Model

    Myelodysplastic Syndromes Benefit from Iron-Restricted Bone Marrow Transplant in Preclinical Mouse Model by Antypiuk, Ada, Martinez, Alberto, Schaeper, Ute, Platzbecker, Uwe, Vinchi, Francesca

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Differential Recovery of Macrophage Iron Deficiency By Oral Iron Formulations Determines Cell Inflammatory Response in Conditions of Iron Deficiency Anemia

    Differential Recovery of Macrophage Iron Deficiency By Oral Iron Formulations Determines Cell Inflammatory Response in Conditions of Iron Deficiency Anemia by Antypiuk, Ada, Sharma, Richa, Brilli, Elisa, Tarantino, Germano, Vinchi, Francesca

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    3207 – GENETIC IRON OVERLOAD EXACERBATES AND PHARMACOLOGICAL IRON RESTRICTION IMPROVES MDS PATHOPHYSIOLOGY IN PRECLINICAL STUDIES

    3207 – GENETIC IRON OVERLOAD EXACERBATES AND PHARMACOLOGICAL IRON RESTRICTION IMPROVES MDS PATHOPHYSIOLOGY IN PRECLINICAL STUDIES by Vinchi, Francesca, Antypiuk, Ada, Vance, S.Zebulon, Dürrenberger, Franz, Manolova, Vania

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Genetic Iron Overload Aggravates and Pharmacological Iron Restriction Improves MDS Pathophysiology in a Preclinical Mouse Model

    Genetic Iron Overload Aggravates and Pharmacological Iron Restriction Improves MDS Pathophysiology in a Preclinical Mouse Model by Vance, S. Zebulon, Antypiuk, Ada, Sharma, Richa, Dürrenberger, Franz, Manolova, Vania, Vinchi, Francesca

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease

    Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease by Sharma, Richa, Antypiuk, Ada, Vance, S. Zebulon, Manwani, Deepa, Pearce, Quentinn, Cox, James E., An, Xiuli, Yazdanbakhsh, Karina, Vinchi, Francesca

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Heme and Iron Aggravate Tissue Damage in Sickle Cell Disease By Driving Macrophage Functional Reprogramming through the Coordinated Suppression of Efferocytosis and Mitochondrial Metabolism

    Heme and Iron Aggravate Tissue Damage in Sickle Cell Disease By Driving Macrophage Functional Reprogramming through the Coordinated Suppression of Efferocytosis and Mitochondrial M... by Sharma, Richa, Vance, S. Zebulon, Antypiuk, Ada, Manwani, Deepa, Pearce, Quentinn, Cox, James E., An, Xiuli, Yazdanbakhsh, Karina, Vinchi, Francesca

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Genetic iron overload aggravates and pharmacological iron restriction improves MDS pathophysiology in a preclinical study

    Genetic iron overload aggravates and pharmacological iron restriction improves MDS pathophysiology in a preclinical study by Antypiuk, Ada, Vance, Steven, Sharma, Richa, Passos, Sara T, Asperti, Michela, Navaneethabalakrishnan, Shobana, Durrenberger, Franz, Manolova, Vania, Vinchi, Prof, Francesca

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: